Overview

TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study wants to determine the activity of a first-line treatment related to Thymidylate Synthetase (TS) Expression. Patients with the diagnosis of non-squamous advanced Non-Small-Cell Lung-Cancer (Stage IV) and without evidence of EGFR mutation may be enclosed in this clinical trial.
Phase:
Phase 2
Details
Lead Sponsor:
Aktion Bronchialkarzinom e.V.
Collaborators:
Eli Lilly and Company
Roche Pharma AG
Treatments:
Bevacizumab
Cisplatin
Pemetrexed